A medical device company has a long-standing relati onship with Bioclinica (>10 years, 380+ studies total) and wanted to increase their data quality while decreasing the monitoring ti me required during their clinical trials. The sponsor is currently an avid user of the Bioclinica EDC and CTMS systems as well as Bioclinica Data Manage-ment services. However, they wanted to decrease the associated ti me and errors by directly populati ng the EDC with their assessment data rather than writi ng the source data on paper for later transcripti on into the EDC.
